Indications and uses
first aid to help prevent infection in: minor cuts scrapes burns
first aid to help prevent infection in: minor cuts scrapes burns
clean the affected area apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage
Drug Facts
Bacitracin zinc 400 units
Neomycin sulfate 5 mg
(equivalent to 3.5 mg of neomycin base)
Polymyxin B sulfate 5000 units
First Aid Antibiotic
first aid to help prevent infection in:
For external use only
Ask a doctor before use if you have deep or puncture wounds, animal bites, or serious burns
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
petrolatum
888.900.2920
prostatfa.com
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | 2 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | 2 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BACITRACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NEOMYCIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| POLYMYXIN B Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58228-5600-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-216e-a910-e053-dadaa90a0b85 | f588bd1b-6087-453a-b268-e1ec4241c37e |
| 58228-5600-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-216e-a910-e053-dadaa90a0b85 | f588bd1b-6087-453a-b268-e1ec4241c37e |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58228-5600-0 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 2 | |
| 58228-5600-1 | Triple Antibiotic | 25 in 1 BOX | OINTMENT | 25 | 2 | |
| 58228-5600-2 | Triple Antibiotic | 25 in 1 BOX | OINTMENT | 25 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58228-5600 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [PROSTAT FIRST AID] | 2 | Legacy NDC, 3 package rows | 20191231_f588bd1b-6087-453a-b268-e1ec4241c37e.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| bacitracin zinc | ACTIVE INGREDIENT | 89Y4M234ES | 1 | |
| neomycin sulfate | ACTIVE INGREDIENT | 057Y626693 | 1 | |
| polymyxin b sulfate | ACTIVE INGREDIENT | 19371312D4 | 1 | |
| bacitracin | ACTIVE MOIETY | 58H6RWO52I | 1 | |
| neomycin | ACTIVE MOIETY | I16QD7X297 | 1 | |
| polymyxin b | ACTIVE MOIETY | J2VZ07J96K | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58228-5600 | 58228-5600-0, 58228-5600-1, 58228-5600-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| bacitracin zinc | 89Y4M234ES | ACTIM |
| neomycin sulfate | 057Y626693 | ACTIM |
| polymyxin b sulfate | 19371312D4 | ACTIM |
| petrolatum | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c821dacb-ebf6-4a85-a292-9be07c3a6377 | f588bd1b-6087-453a-b268-e1ec4241c37e | 2013-09-20 | Warnings | c821dacb-ebf6-4a85-a292-9be07c3a6377 f588bd1b-6087-453a-b268-e1ec4241c37e |
Adverse event summaries are temporarily unavailable. Other product information remains available.